Xylem Inc. reports third quarter 2012 results
Third quarter adjusted net income was
Third quarter revenue up 3 percent in constant currencies to
Gross margin climbs 130 basis points to 40.2 percent as Customer Excellence and cost reduction initiatives drive profitability; adjusted operating margin was 12.9 percent
Company completes second acquisition in 2012 with the purchase of Heartland Pump, bolstering industrial dewatering portfolio
"As we mark our first anniversary as a stand-alone water company, our
performance showcases both the strength of our global portfolio, with 9
percent constant currency revenue growth in the emerging markets, and
our strategic focus on margin expansion through the execution of our
Customer Excellence sales initiative and cost discipline,” said
McClain said the company continues to move forward with restructuring
and realignment initiatives, and now foresees approximately
Business Segment Results
Water Infrastructure
Xylem’s Water Infrastructure businesses provide equipment and services focused on the transport, treatment and testing of water and wastewater in the public utility and industrial markets.
-
Third quarter 2012 segment revenue was
$595 million , up 7 percent in constant currencies, and up 2 percent as reported, with growth in public utility activity in all regions more than offsetting weakness in industrial. - Third quarter adjusted segment operating margin was 15.0 percent. Stand-alone costs negatively impacted operating margin 50 basis points for the third quarter of 2012.
Applied Water
Xylem’s Applied Water businesses provide equipment and services in the residential and commercial building services, general industrial and agricultural markets.
-
Third quarter 2012 segment revenue was
$350 million , down 2 percent in constant currencies, and 5 percent as reported, reflecting comparison to a particularly strong third quarter 2011, and ongoing weakness in commercial building services. - Third quarter adjusted segment operating margin was 12.6 percent. Stand-alone costs negatively impacted operating margin 60 basis points for the third quarter of 2012.
More detail available
Supplemental information on Xylem’s third quarter earnings and reconciliations for certain non-GAAP items is posted at investors.xyleminc.com.
About Xylem
The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all -- that which occurs in nature. For more information, please visit us at www.xyleminc.com.
Forward-Looking Statements
This document contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “target” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.
These forward-looking statements include, but are not limited to,
statements about the separation of
Caution should be taken not to place undue reliance on any such
forward-looking statements because they involve risks, uncertainties and
other factors that could cause actual results to differ materially from
those expressed or implied in, or reasonably inferred from, such
statements. The Company undertakes no obligation to publicly update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by law. In
addition, forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
the Company’s historical experience and our present expectations or
projections. These risks and uncertainties include, but are not limited
to, those set forth in Item 1A in our Annual Report on Form 10-K, and
those described from time to time in subsequent reports filed with the
*The 2011 normalized earnings per share reflect adjustments (including interest expense, stand-alone costs, and special tax items) to our GAAP results to better illustrate year-over-year performance. The normalized earnings are intended to give a representation of our performance had Xylem been a stand-alone company in 2011.
XYLEM INC. AND SUBSIDIARIES |
||||||||||||
CONDENSED CONSOLIDATED AND COMBINED INCOME STATEMENTS (Unaudited) |
||||||||||||
(in millions, except per share data) |
||||||||||||
|
||||||||||||
Three Months | Nine Months | |||||||||||
For the periods ended September 30, | 2012 | 2011 | 2012 | 2011 | ||||||||
Revenue | $ | 931 | $ | 939 | $ | 2,822 | $ | 2,800 | ||||
Cost of revenue | 557 | 574 | 1,702 | 1,719 | ||||||||
Gross profit | 374 | 365 | 1,120 | 1,081 | ||||||||
Selling, general and administrative expenses | 231 | 215 | 682 | 643 | ||||||||
Research and development expenses | 24 | 23 | 80 | 73 | ||||||||
Restructuring and asset impairment charges, net | 4 | 2 | 4 | 2 | ||||||||
Separation costs | 4 | 46 | 15 | 67 | ||||||||
Operating income | 111 | 79 | 339 | 296 | ||||||||
Interest expense | 14 | 1 | 41 | 2 | ||||||||
Other non-operating income, net | 3 | 4 | 1 | 5 | ||||||||
Income before taxes | 100 | 82 | 299 | 299 | ||||||||
Income tax expense | 28 | 5 | 75 | 72 | ||||||||
Net income | $ | 72 | $ | 77 | $ | 224 | $ | 227 | ||||
Earnings per share: | ||||||||||||
Basic | $ | 0.39 | $ | 0.42 |
$ |
1.20 | $ | 1.23 | ||||
Diluted | $ | 0.38 | $ | 0.42 |
$ |
1.20 | $ | 1.23 | ||||
Weighted average number of shares: | ||||||||||||
Basic | 185.9 | 184.6 | 185.7 | 184.6 | ||||||||
Diluted | 186.3 | 184.6 | 186.2 | 184.6 | ||||||||
Dividends declared per share | $ | 0.1012 | $ | ─ | $ |
0.3036 |
$ | ─ | ||||
XYLEM INC. AND SUBSIDIARIES | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
|||||||
(in millions, except per share amounts) |
|||||||
September 30, |
|
December 31, | |||||
2012 | 2011 | ||||||
(Unaudited) | |||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 424 | $ | 318 | |||
Receivables, less allowances for discounts and doubtful accounts
of $33 and $37 in 2012 and 2011, respectively |
801 |
756 |
|||||
Inventories, net | 467 | 426 | |||||
Prepaid and other current assets | 106 | 97 | |||||
Deferred income tax assets | 36 | 45 | |||||
Total current assets | 1,834 | 1,642 | |||||
Property, plant and equipment, net | 464 | 463 | |||||
Goodwill | 1,621 | 1,610 | |||||
Other intangible assets, net | 485 | 505 | |||||
Other non-current assets | 192 | 173 | |||||
Total assets | $ | 4,596 | $ | 4,393 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 316 | $ | 322 | |||
Accrued and other current liabilities | 456 | 490 | |||||
Short-term borrowings and current maturities of long-term debt | 13 | 5 | |||||
Total current liabilities | 785 | 817 | |||||
Long-term debt | 1,199 | 1,201 | |||||
Accrued postretirement benefits | 319 | 316 | |||||
Deferred income tax liability | 170 | 165 | |||||
Other non-current accrued liabilities | 69 | 67 | |||||
Total liabilities | 2,542 | 2,566 | |||||
Commitments and contingencies
Stockholders’ equity: |
|||||||
Common Stock – authorized 750.0 shares, par value $0.01 per share: | |||||||
Issued 186.0 shares and 184.6 shares in 2012 and 2011, respectively | 2 | 2 | |||||
Capital in excess of par value | 1,699 | 1,663 | |||||
Retained earnings | 206 | 40 | |||||
Treasury stock – at cost 0.2 shares and 0 shares in 2012 and 2011, respectively | (6 | ) | ─ | ||||
Accumulated other comprehensive income | 153 | 122 | |||||
Total stockholders’ equity | 2,054 | 1,827 | |||||
Total liabilities and stockholders’ equity | $ | 4,596 | $ | 4,393 | |||
XYLEM INC. AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS (Unaudited) |
||||||||
(in millions) |
||||||||
For the nine months ended September 30, | 2012 | 2011 | ||||||
Operating Activities | ||||||||
Net income | $ | 224 | $ | 227 | ||||
Adjustments to reconcile net income to net cash provided
by operating activities: |
||||||||
Depreciation and amortization | 103 | 104 | ||||||
Share-based compensation | 16 | 7 | ||||||
Non-cash separation costs | — | 8 | ||||||
Restructuring and asset impairment charges | 4 | 2 | ||||||
Payments for restructuring | — | (7 | ) | |||||
Changes in assets and liabilities (net of acquisitions): | ||||||||
Changes in receivables | (33 | ) | (58 | ) | ||||
Changes in inventories | (33 | ) | (40 | ) | ||||
Changes in accounts payable | (7 | ) | (31 | ) | ||||
Changes in accrued liabilities | (30 | ) | 14 | |||||
Changes in accrued taxes | 1 | 4 | ||||||
Net changes in other assets and liabilities | (14 | ) | 18 | |||||
Other, net | (1 | ) | 4 | |||||
Net Cash - Operating activities | 230 | 252 | ||||||
Investing Activities | ||||||||
Capital expenditures | (81 | ) | (79 | ) | ||||
Acquisitions, net of cash required | (12 | ) | (309 | ) | ||||
Proceeds from the sale of property, plant and equipment | 4 | 9 | ||||||
Other, net | — | 2 | ||||||
Net Cash - Investing activities | (89 | ) | (377 | ) | ||||
Financing Activities | ||||||||
Net transfer to former parent | (9 | ) | (1,012 | ) | ||||
Issuance of short-term debt | 12 | 5 | ||||||
Issuance of senior notes, net of discount | — | 1,189 | ||||||
Principal payments of debt and capital lease obligations | (6 | ) | — | |||||
Purchase of common stock | (4 | ) | — | |||||
Proceeds from exercise of employee stock options | 22 | — | ||||||
Dividends paid | (56 | ) | — | |||||
Net Cash - Financing activities | (41 | ) | 182 | |||||
Effect of exchange rate changes on cash | 6 | (4 | ) | |||||
Net change in cash and cash equivalents | 106 | 53 | ||||||
Cash and cash equivalents at beginning of year | 318 | 131 | ||||||
Cash and cash equivalents at end of year | $ | 424 | $ | 184 | ||||
Supplemental disclosure of cash flow information: Cash paid during the period for: |
||||||||
Interest | $ | 38 | $ | — | ||||
Income taxes (net of refunds received) | $ | 76 | $ | 37 | ||||
Xylem Inc. Non-GAAP Measures | |
Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators: |
|
“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations, intercompany transactions, and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period. |
|
“Constant currency” defined as financial results adjusted for currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar. | |
“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude for non-recurring separation costs associated with the Xylem spin-off from ITT Corporation as well as non-recurring restructuring and realignment costs. |
|
"Adjusted Operating Income", "Adjusted Segment Operating Income", and “Adjusted EPS” defined as operating income and earnings per share, adjusted to exclude non-recurring separation costs associated with the Xylem spin-off from ITT Corporation, non-recurring restructuring and realignment costs and tax-related special items. |
|
“Normalized EPS” defined as adjusted earnings per share, as well as adjustments to reflect the incremental current period amount of interest expense and stand-alone costs in the prior comparable period. |
|
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt. |
|
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||||||||||
Reported vs. Organic & Constant Currency Order Growth | |||||||||||||||||||||||||||
($ Millions) | |||||||||||||||||||||||||||
(As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||||||||||||
(A) | (B) | (C) | (D) | (E) | (F) = B+C+D+E | (G) = F/A | (H) = (B + D) / A | ||||||||||||||||||||
Change | % Change |
|
Change | % Change | |||||||||||||||||||||||
Orders | Orders | 2012 v. 2011 | 2012 v. 2011 |
Acquisitions / Divestitures |
FX Contribution | Eliminations | Adj. 2012 v. 2011 | Adj. 2012 v. 2011 | |||||||||||||||||||
2012 | 2011 | ||||||||||||||||||||||||||
Nine Months Ended September 30 | |||||||||||||||||||||||||||
Xylem Inc. | 2,856 | 2,942 | (86 | ) | -2.9 | % | (88 | ) | 108 | - | (66 | ) | -2.2 | % | 0.7 | % | |||||||||||
Water infrastructure | 1,819 | 1,865 | (46 | ) | -2.5 | % | (88 | ) | 82 | - | (52 | ) | -2.8 | % | 1.9 | % | |||||||||||
Applied Water | 1,086 | 1,122 | (36 | ) | -3.2 | % | - | 30 | (8 | ) | (14 | ) | -1.2 | % | -0.5 | % | |||||||||||
Quarter Ended September 30, 2012 | |||||||||||||||||||||||||||
Xylem Inc. | 882 | 966 | (84 | ) | -8.7 | % | (21 | ) | 39 | - | (66 | ) | -6.8 | % | -4.7 | % | |||||||||||
Water infrastructure | 564 | 621 | (57 | ) | -9.2 | % | (21 | ) | 29 | - | (49 | ) | -7.9 | % | -4.5 | % | |||||||||||
Applied Water | 334 | 358 | (24 | ) | -6.7 | % | - | 12 | (5 | ) | (17 | ) | -4.7 | % | -3.4 | % | |||||||||||
Quarter Ended June 30 | |||||||||||||||||||||||||||
Xylem Inc. | 970 | 998 | (28 | ) | -2.8 | % | (30 | ) | 51 | - | (7 | ) | -0.7 | % | 2.3 | % | |||||||||||
Water infrastructure | 617 | 632 | (15 | ) | -2.4 | % | (30 | ) | 40 | - | (5 | ) | -0.8 | % | 4.0 | % | |||||||||||
Applied Water | 370 | 383 | (13 | ) | -3.4 | % | - | 13 | (2 | ) | (2 | ) | -0.5 | % | 0.0 | % | |||||||||||
Quarter Ended March 31 | |||||||||||||||||||||||||||
Xylem Inc. | 1,004 | 978 | 26 | 2.7 | % | (37 | ) | 18 | - | 7 | 0.7 | % | 4.5 | % | |||||||||||||
Water infrastructure | 638 | 612 | 26 | 4.2 | % | (37 | ) | 13 | - | 2 | 0.3 | % | 6.4 | % | |||||||||||||
Applied Water | 382 | 381 | 1 | 0.3 | % | - | 5 | (1 | ) | 5 | 1.3 | % | 1.6 | % | |||||||||||||
Note: Due to rounding the sum of segment amounts may not agree to Xylem totals. | |||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||||||||||
Reported vs. Organic & Constant Currency Revenue | |||||||||||||||||||||||||||
($ Millions) | |||||||||||||||||||||||||||
(As Reported - GAAP) | (As Adjusted - Organic) | Constant Currency | |||||||||||||||||||||||||
(A) | (B) | (C) | (D) | (E) | (F) = B+C+D+E | (G) = F/A | (H) = (B + D) / A | ||||||||||||||||||||
Change | % Change |
|
Change | % Change | |||||||||||||||||||||||
Revenue | Revenue | 2012 v. 2011 | 2012 v. 2011 |
Acquisitions / Divestitures |
FX Contribution | Eliminations | Adj. 2012 v. 2011 | Adj. 2012 v. 2011 | |||||||||||||||||||
2012 | 2011 | ||||||||||||||||||||||||||
Nine Months Ended September 30 | |||||||||||||||||||||||||||
Xylem Inc. | 2,822 | 2,800 | 22 | 0.8 | % | (87 | ) | 101 | - | 36 | 1.3 | % | 4.4 | % | |||||||||||||
Water infrastructure | 1,788 | 1,737 | 51 | 2.9 | % | (87 | ) | 75 | - | 39 | 2.2 | % | 7.3 | % | |||||||||||||
Applied Water | 1,078 | 1,108 | (30 | ) | -2.7 | % | - | 30 | (3 | ) | (3 | ) | -0.3 | % | 0.0 | % | |||||||||||
Quarter Ended September 30, 2012 | |||||||||||||||||||||||||||
Xylem Inc. | 931 | 939 | (8 | ) | -0.9 | % | (21 | ) | 38 | - | 9 | 1.0 | % | 3.2 | % | ||||||||||||
Water infrastructure | 595 | 584 | 11 | 1.9 | % | (21 | ) | 28 | - | 18 | 3.1 | % | 6.7 | % | |||||||||||||
Applied Water | 350 | 368 | (18 | ) | -4.9 | % | - | 12 | (2 | ) | (8 | ) | -2.2 | % | -1.6 | % | |||||||||||
Quarter Ended June 30 | |||||||||||||||||||||||||||
Xylem Inc. | 966 | 971 | (5 | ) | -0.5 | % | (32 | ) | 49 | - | 12 | 1.2 | % | 4.5 | % | ||||||||||||
Water infrastructure | 609 | 602 | 7 | 1.2 | % | (32 | ) | 37 | (1 | ) | 11 | 1.8 | % | 7.3 | % | ||||||||||||
Applied Water | 373 | 385 | (12 | ) | -3.1 | % | - | 13 | (1 | ) | - | 0.0 | % | 0.3 | % | ||||||||||||
Quarter Ended March 31 | |||||||||||||||||||||||||||
Xylem Inc. | 925 | 890 | 35 | 3.9 | % | (34 | ) | 14 | - | 15 | 1.7 | % | 5.5 | % | |||||||||||||
Water infrastructure | 584 | 551 | 33 | 6.0 | % | (34 | ) | 10 | 1 | 10 | 1.8 | % | 7.8 | % | |||||||||||||
Applied Water | 355 | 355 | - | 0.0 | % | - | 5 | - | 5 | 1.4 | % | 1.4 | % | ||||||||||||||
Note: Due to rounding the sum of segment amounts may not agree to Xylem totals. | |||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | ||||||||||||||
Adjusted Diluted EPS | ||||||||||||||
For The Three and Nine Months Ended September 30, 2012 & 2011 | ||||||||||||||
($ Millions, except per share amounts) | ||||||||||||||
Q1 2012 | Q2 2012 | Q3 2012 | YTD 2012 | |||||||||||
Net Income | 63 | 89 | 72 | 224 | ||||||||||
Separation Costs, Net of Tax | 4 | 4 | 3 | 11 | ||||||||||
Restructuring & Realignment, Net of Tax | - | - | 4 | 4 | ||||||||||
Adjusted Net Income before Special Tax Items | 67 | 93 | 79 | 239 | ||||||||||
Special Tax Items | - | (1 | ) | 4 | 3 | |||||||||
Adjusted Net Income | 67 | 92 | 83 | 242 | ||||||||||
Diluted Earnings per Share | $ | 0.34 | $ | 0.48 | $ | 0.38 | $ | 1.20 | ||||||
Separation Costs per Share | $ | 0.02 | $ | 0.02 | $ | 0.02 | $ | 0.06 | ||||||
Restructuring & Realignment Costs per Share | $ | 0.00 | $ | 0.00 | $ | 0.02 | $ | 0.02 | ||||||
Adjusted Diluted EPS before Special Tax Items | $ | 0.36 | $ | 0.50 | $ | 0.42 | $ | 1.28 | ||||||
Special Tax Items per Share | $ | 0.00 | ($0.01 | ) | $ | 0.02 | $ | 0.01 | ||||||
Adjusted Diluted EPS | $ | 0.36 | $ | 0.49 | $ | 0.44 | $ | 1.29 | ||||||
Q1 2011 | Q2 2011 | Q3 2011 | YTD 2011 | |||||||||||
Net Income | 78 | 72 | 77 | 227 | ||||||||||
Separation Costs, Net of Tax | 2 | 27 | 25 | 54 | ||||||||||
Adjusted Net Income before Special Tax Items | 80 | 99 | 102 | 281 | ||||||||||
Special Tax Items | - | 4 | (1 | ) | 3 | |||||||||
Adjusted Net Income | 80 | 103 | 101 | 284 | ||||||||||
Diluted Earnings per Share | $ | 0.42 | $ | 0.39 | $ | 0.42 | $ | 1.23 | ||||||
Separation Costs per Share | $ | 0.01 | $ | 0.15 | $ | 0.13 | $ | 0.29 | ||||||
Adjusted Diluted EPS before Special Tax Items | $ | 0.43 | $ | 0.54 | $ | 0.55 | $ | 1.52 | ||||||
Special Tax Items per Share | $ | 0.00 | $ | 0.02 | ($0.01 | ) | $ | 0.01 | ||||||
Adjusted Diluted EPS | $ | 0.43 | $ | 0.56 | $ | 0.54 | $ | 1.53 | ||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||
Adjusted Operating Income | |||||||||||||
($ Millions) | |||||||||||||
Q3 | YTD | ||||||||||||
'12 | '11 | '12 | '11 | ||||||||||
Total Revenue | |||||||||||||
• Total Xylem | 931 | 939 | 2,822 | 2,800 | |||||||||
• Water Infrastructure | 595 | 584 | 1,788 | 1,737 | |||||||||
• Applied Water | 350 | 368 | 1,078 | 1,108 | |||||||||
Operating Income | |||||||||||||
• Total Xylem | 111 | 79 | 339 | 296 | |||||||||
• Water Infrastructure | 85 | 87 | 253 | 245 | |||||||||
• Applied Water | 43 | 37 | 135 | 133 | |||||||||
Operating Margin | |||||||||||||
• Total Xylem | 11.9 | % | 8.4 | % | 12.0 | % | 10.6 | % | |||||
• Water Infrastructure | 14.3 | % | 14.9 | % | 14.1 | % | 14.1 | % | |||||
• Applied Water | 12.3 | % | 10.0 | % | 12.5 | % | 12.0 | % | |||||
Separation Costs | |||||||||||||
• Total Xylem | 4 | 46 | 15 | 67 | |||||||||
• Water Infrastructure | - | 8 | 3 | 10 | |||||||||
• Applied Water | 1 | 9 | 2 | 9 | |||||||||
Restructuring & Realignment Costs | |||||||||||||
• Total Xylem | 5 | - | 5 | - | |||||||||
• Water Infrastructure | 4 | - | 4 | - | |||||||||
• Applied Water | - | - | - | - | |||||||||
Adjusted Operating Income* | |||||||||||||
• Total Xylem | 120 | 125 | 359 | 363 | |||||||||
• Water Infrastructure | 89 | 95 | 260 | 255 | |||||||||
• Applied Water | 44 | 46 | 137 | 142 | |||||||||
Adjusted Operating Margin* | |||||||||||||
• Total Xylem | 12.9 | % | 13.3 | % | 12.7 | % | 13.0 | % | |||||
• Water Infrastructure | 15.0 | % | 16.3 | % | 14.5 | % | 14.7 | % | |||||
• Applied Water | 12.6 | % | 12.5 | % | 12.7 | % | 12.8 | % | |||||
*Adjusted Operating Income excludes non-recurring separation, restructuring & realignment costs | |||||||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||||||||||||||||||||
Normalized and Adjusted Diluted EPS | |||||||||||||||||||||||||||||||||||||
($ Millions, except per share amounts) | |||||||||||||||||||||||||||||||||||||
Q3 2011 | Q3 2012 | ||||||||||||||||||||||||||||||||||||
As Reported | Adjustments | Adjusted | Adjustments | Normalized | As Reported | Adjustments | Adjusted | ||||||||||||||||||||||||||||||
Total Revenue | 939 | 939 | 939 | 931 | 931 | ||||||||||||||||||||||||||||||||
Operating Income | 79 | 46 | a | 125 | (8 | ) | c | 117 | 111 | 9 | a | 120 | |||||||||||||||||||||||||
Operating Margin | 8.4 | % | 13.3 | % | 12.5 | % | 11.9 | % | 12.9 | % | |||||||||||||||||||||||||||
Interest Expense | (1 | ) | (1 | ) | (13 | ) | d | (14 | ) | (14 | ) | (14 | ) | ||||||||||||||||||||||||
Other Non-Operating Income (Expense) | 4 | 4 | 4 | 3 | 3 | ||||||||||||||||||||||||||||||||
Income before Taxes | 82 | 46 | 128 | (21 | ) | 107 | 100 | 9 | 109 | ||||||||||||||||||||||||||||
Provision for Income Taxes | (5 | ) | (22 | ) | b | (27 | ) | 4 | e | (23 | ) | (28 | ) | 2 | b | (26 | ) | ||||||||||||||||||||
Net Income | 77 | 24 | 101 | (17 | ) | 84 | 72 | 11 | 83 | ||||||||||||||||||||||||||||
Diluted Shares | 184.6 | 184.6 | 186.3 | 186.3 | |||||||||||||||||||||||||||||||||
Diluted EPS | $ | 0.42 | $ | 0.12 | $ | 0.54 | $ | (0.09 | ) | $ | 0.45 | $ | 0.38 | $ | 0.06 | $ | 0.44 | ||||||||||||||||||||
a | One time separation, restructuring & realignment costs | ||||||||||||||||||||||||||||||||||||
b | Tax impact of one time separation costs and special tax items | ||||||||||||||||||||||||||||||||||||
c |
Incremental stand-alone costs incurred in 2012 |
||||||||||||||||||||||||||||||||||||
d | Incremental interest expense on long-term debt entered into in conjunction with the spin | ||||||||||||||||||||||||||||||||||||
e |
Tax impact of incremental interest expense and stand-alone costs incurred in 2012 |
||||||||||||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | ||||||
Net Cash - Operating Activities vs. Free Cash Flow | ||||||
For The Nine Months Ended September 30, 2012 & 2011 | ||||||
($ Millions) | ||||||
Nine Months Ended | ||||||
2012 | 2011 | |||||
Net Cash - Operating Activities | 230 | 252 | ||||
Capital Expenditures | (81 | ) | (79 | ) | ||
Free Cash Flow, including separation costs | 149 | 173 | ||||
Cash Paid for Separation Costs (incl. Capex) | 22 | 62 | ||||
Free Cash Flow, excluding separation costs | 171 | 235 | ||||
Net Income | 224 | 227 | ||||
Separation Costs, net of tax (incl. tax friction) | 11 | 54 | ||||
Adjusted Net Income | 235 | 281 | ||||
Free Cash Flow Conversion | 73 | % | 84 | % | ||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||||||||||||||||||||
Guidance | |||||||||||||||||||||||||||||||||
($ Millions, except per share amounts) | |||||||||||||||||||||||||||||||||
Illustration of Mid Point Guidance | |||||||||||||||||||||||||||||||||
2012 Guidance | |||||||||||||||||||||||||||||||||
FY '11 | FY '12 | ||||||||||||||||||||||||||||||||
As Reported | Adjustments | Adjusted | Adjustments | Normalized | As Projected | Adjustments | Adjusted | ||||||||||||||||||||||||||
Total Revenue | 3,803 | 3,803 | 3,803 | 3,800 | 3,800 | ||||||||||||||||||||||||||||
Segment Operating Income | 503 | 29 | a | 532 | (10 | ) | d | 522 | 516 | 25 | h,i | 541 | |||||||||||||||||||||
Segment Operating Margin | 13.2 | % | 14.0 | % | 13.7 | % | 13.6 | % | 14.2 | % | |||||||||||||||||||||||
Corporate Expense | 108 | (58 | ) | b | 50 | 18 | e | 68 | 68 | (15 | ) | h | 53 | ||||||||||||||||||||
Operating Income | 395 | 87 | 482 | (28 | ) | 454 | 448 | 40 | 488 | ||||||||||||||||||||||||
Operating Margin | 10.4 | % | 12.7 | % | 11.9 | % | 11.8 | % | 12.8 | % | |||||||||||||||||||||||
Interest Expense | (17 | ) | (17 | ) | (39 | ) | f | (56 | ) | (54 | ) | (54 | ) | ||||||||||||||||||||
Other Non-Operating Income (Expense) | 5 | 5 | 5 | (1 | ) | (1 | ) | ||||||||||||||||||||||||||
Income before Taxes | 383 | 87 | 470 | (67 | ) | 403 | 393 | 40 | 433 | ||||||||||||||||||||||||
Provision for Income Taxes | (104 | ) | (8 | ) | c | (112 | ) | 16 | g | (96 | ) | (99 | ) | (7 | ) | j | (106 | ) | |||||||||||||||
Net Income | 279 | 79 | 358 | (51 | ) | 307 | 294 | 33 | 327 | ||||||||||||||||||||||||
Diluted Shares | 185.3 | 185.3 | 186.2 | 186.2 | |||||||||||||||||||||||||||||
Diluted EPS | $ | 1.50 | $ | 0.43 | $ | 1.93 | $ | (0.27 | ) | 1.66 | 1.58 | 0.18 | 1.76 | ||||||||||||||||||||
a | One time separation costs incurred at the segment level | ||||||||||||||||||||||||||||||||
b | One time separation costs incurred at the corporate level | ||||||||||||||||||||||||||||||||
c | Net tax impact of above items, plus the addition of 2011 special tax items | ||||||||||||||||||||||||||||||||
d |
Incremental stand-alone costs to be incurred in 2012 at the segment level ($10M) |
||||||||||||||||||||||||||||||||
e |
Incremental stand-alone costs to be incurred in 2012 at the corporate level ($18M) |
||||||||||||||||||||||||||||||||
f | Incremental interest expense on long-term debt to be incurred in 2012 | ||||||||||||||||||||||||||||||||
g |
Tax impact of incremental interest expense and stand-alone costs to be incurred in 2012 |
||||||||||||||||||||||||||||||||
h | Expected one time separation costs of $5M and $15M to be incurred at the segments and headquarters, respectively. | ||||||||||||||||||||||||||||||||
i | Restructuring & realignment costs of $20M to be incurred at the segments. | ||||||||||||||||||||||||||||||||
j | Tax impact of one time separation, restructuring & realignment costs expected to be incurred in 2012 and tax special items realized through Q3 2012. | ||||||||||||||||||||||||||||||||
Xylem Inc. Non-GAAP Reconciliation | |||||||||||||||
Adjusted Operating Income | |||||||||||||||
($ Millions) | |||||||||||||||
Mid Point Guidance | |||||||||||||||
2008 | 2009 | 2010 | 2011 | 2012E | |||||||||||
Revenue | 3,291 | 2,849 | 3,202 | 3,803 | 3,800 | ||||||||||
Operating Income | 315 | 276 | 388 | 395 | 448 | ||||||||||
Operating Margin | 9.6 | % | 9.7 | % | 12.1 | % | 10.4 | % | 11.8 | % | |||||
Restructuring & Realignment | 41 | 31 | 15 | - | 20 | ||||||||||
Separation Costs | - | - | - | 87 | 20 | ||||||||||
Adjusted Operating Income | 356 | 307 | 403 | 482 | 488 | ||||||||||
Adjusted Operating Margin | 10.8 | % | 10.8 | % | 12.6 | % | 12.7 | % | 12.8 | % | |||||
Stand-alone Costs |
- | - | - | 5 | 28 | ||||||||||
Adj. Operating Income, excl. Stand-alone Costs |
356 | 307 | 403 | 487 | 516 | ||||||||||
Adjusted Operating Margin, excl. Stand-alone Costs |
10.8 | % | 10.8 | % | 12.6 | % | 12.8 | % | 13.6 | % | |||||
Source:
Xylem Inc.
Media
Tom Glover, +1-914-323-5891
Tom.Glover@xyleminc.com
or
Investors
Phil
De Sousa, +1-914-323-5930
Phil.DeSousa@xyleminc.com